Abstract
Pretreatment of murine leukaemia L1210 cells with non-lethal concentrations of various antimetabolites increased thein vitro invasive capacity of these cells into monolayers of rat embryo fibroblasts. The increase in invasive capacity was partly correlated with the induced cell cycle arrest. The concomitant increase in cell surface fucosylation and inhibition of invasion with sulphate indicate a role for glycoproteins in this process. Our results suggest that treatment with antimetabolites may lead to a more aggressive phenotype by altering cell surface properties.
Similar content being viewed by others
References
Lotan R and Nicolson GL, 1988, Can anticancer therapy be improved by sequential use of cytotoxic and cytostatic (differentiating or immunomodulating) agents to suppress tumor cell phenotypic diversification?Biochem Pharmacol,37, 149–54.
Golos B and Malec J, 1989, Enhancement of methotrexate-induced growth inhibition, cell killing and DNA lesions in cultured L5178Y cells by the reduction of DNA repair efficiency.Biochem Pharmacol,38, 1743–8.
Muus P, Van den Bogert C, De Vries H,et al. 1991, 1-Β-d-Arabinofuranosylcytosine (Ara-C) enhances mitochondrial activities in human leukaemic cells.Br J Cancer,64, 29–34.
Peters GJ, Pinedo HM, Ferwerda W, De Graaf TW and Van Dijk W, 1990, Do antimetabolites interfere with the glycosylation of cellular glycoconjugates?Eur J Cancer,26, 516–23.
Pinedo HM and Peters GJ, 1988, Fluorouracil: biochemistry and pharmacology.J Clin Oncol,6, 1653–64.
Schwartz EL, Chamberlin H and Brechbühl AB, 1990, Inhibition of c-myc expression in human promyelocytic leukemia and colon adenocarcinoma cells by 6-thioguanine.Biochem Pharmacol,40, 2449–55.
De Graaf TW, Slot SS, Peters GJ and Van Dijk W, 1993, Changes in glycosylation of L1210 cells after exposure to various antimetabolites.Eur J Cancer,29A, 1760–5.
Berrada A, Vavasseur F, Le Pendu J and Meflah K, 1990, Correlation between cell surface oligosaccharides and tissue target-selective adhesion of two rat adenocarcinoma cell lines.Invasion Metastasis,10, 352–71.
Collard JG, Schijven JF, Bikker A,et al. 1986, Cell surface sialic acid and the invasive and metastatic potential of T-cell hybridomas.Cancer Res,46, 3521–7.
Finne J, Castori S, Feizi T and Burger MM, 1989, Lectin-resistant variants and revertants of mouse melanoma cells: differential expression of a fucosylated cell-surface antigen and altered metastasizing capacity.Int J Cancer,43, 300–4.
Dennis JW, Laferté S, Yagel S. and Breitman ML, 1989, Asparagine-linked oligosaccharides associated with metastatic cancer.Cancer Cells,1, 87–92.
Vavasseur F, Berrada A, Heuzé F, Jotercau F and Meflah K, 1990, Fucose and galactose receptor and liver recognition by lymphoma cells.Int J Cancer,45, 744–51.
Springer TA and Lasky LA, 1991, Sticky sugars for selectins.Nature,349, 196–7.
Easton EW, Blokland I, Geldof AA, Rao BR and Van den Eijnden DH, 1992, The metastatic potential of rat prostrate tumor variant R3327-MatLyLu is correlated with an increased activity ofN-acetylglucosaminyl transferase III and V.FEBS Lett,308, 46–9.
Parish CR, Bradbury MG, Weston SA and Warren HS, 1992, Carbohydrate recognition molecules on lymphocytes.Biochem Soc Trans,20, 295–7.
Rider CC, 1992, Sulphated glycoconjugates in the immune system.Biochem Soc Trans,20, 291–5.
Saitoh O, Wang W-C, Lotan R and Fukuda M, 1992, Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials.J Biol Chem,267, 5700–11.
Esko JD, Rostand KS and Weinke JL, 1988, Tumor formation dependent on proteoglycan biosynthesis.Science,241, 1092–5.
Nicolson GL and Custead SE, 1985, Effects of chemotherapeutic drugs on platelet and metastatic tumor cell-endothelial cell interactions as a model for assessing vascular endothelial integrity.Cancer Res,45, 331–6.
Van Putten LM, Kram LKJ, Van Dierendonck HHC, Smink T and Füzy M, 1975, Enhancement by drugs of metastatic lung nodule formation after intravenous tumour cell injection.Int J Cancer,15, 588–95.
Pogàny G, Lapis K, Jeney A,et al. 1992, The effects of 5-hexyl-2-deoxycytidine on proteoglycan production, membrane phenotype and invasiveness of tumour cells.Proc Am Assoc Cancer Res,33, 525.
McMillan TJ and Hart IR, 1986, Enhanced experimental metastatic capacity of a murine melanoma following pre-treatment with anticancer drugs.Clin Exp Metastasis,4, 285–92.
McMillan TJ and Hart IR, 1987, Can cancer chemotherapy enhance the malignant behaviour of tumours?Cancer Metastasis Rev,6, 503–20.
Müller R and Müller D, 1984, Co-transfection of normal NIH/3T3 DNA and retroviral LTR sequences: a novel strategy for the detection of potential c-onc genes.EMBO J,3, 1121–7.
Collard JG, Van de Pol M, Scheffer A,et al. 1987, Location of genes involved in invasion and metastasis on human chromosome 7.Cancer Res,47, 6666–70.
Palmeiro E, Sikora K and Foster CS, 1990, Cellcycle expression of prostatic tumour oligosaccharides analysed using dual-parameter flow cytometry.Biochem Soc Trans,18, 1285–7.
Keys BJ, Hoyle M and Millis AJT, 1987, Cell cycle dependent expression of a glucose regulated cell surface glycoprotein.In Vitro,17, 769–76.
Kalvelage B and Koch G, 1982, Studies on HeLa cells surface glycopeptides alterations in membrane structure during the cell cycle.Eur J Cell Biol,28, 233–7.
Scheideler MA, Lockney MW and Dawson G, 1984, Cell-cycle dependence of a ganglioside glycosyltransferase activity and its inhibition by enkephalin in a neurotumor cell line.J Neurochem,42, 1175–82.
Erikstein BK, Funderund S, Beiske K,et al. 1992, Cell cycle-dependent regulation of CDw75 (Β-galactosideα-2,6-sialyltransferase) on human B lymphocytes.Eur J Immunol,22, 1149–55.
Bolscher JGM, Bruyneel EA, Van Rooy H,et al. 1989, Decreased fucose incorporation in cell surface carbohydrates is associated with inhibition of invasion.Clin Exp Metastasis,7, 557–69.
Debray H and Montreuil J, 1992, Specificity of lectins toward oligosaccharidic sequences belonging to N- and O-glycosylproteins. In: Breborowicz J, Mackiewicz A, eds.Affinity Electrophoresis: Principles and Application. London: CRC Press, pp. 23–57.
Peters GJ, Schornagel JH and Milano GA, 1993, Clinical pharmocokinetics of antimetabolites.Cancer Surveys,17, 123–56.
Wolverton SE, 1992, Monitoring for adverse effects from systemic drugs used in dermatology.J Am Acad Dermatol,26, 661–79.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
De Graaf, T.W., Peters, G.J. & van Dijk, W. Antimetabolite-induced increases in the invasive capacity of murine leukaemia L1210 cells. Clin Exp Metast 12, 134–142 (1994). https://doi.org/10.1007/BF01753980
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01753980